"Nasal Lavage Fluid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Fluid obtained by THERAPEUTIC IRRIGATION or washout of the nasal cavity and NASAL MUCOSA. The resulting fluid is used in cytologic and immunologic assays of the nasal mucosa such as with the NASAL PROVOCATION TEST in the diagnosis of nasal hypersensitivity.
| Descriptor ID |
D017817
|
| MeSH Number(s) |
E05.927.573.500
|
| Concept/Terms |
Nasal Lavage Fluid- Nasal Lavage Fluid
- Lavage Fluid, Nasal
- Nasal Lavage Fluids
- Nasal Washings
- Nasal Washing
- Washing, Nasal
|
Below are MeSH descriptors whose meaning is more general than "Nasal Lavage Fluid".
Below are MeSH descriptors whose meaning is more specific than "Nasal Lavage Fluid".
This graph shows the total number of publications written about "Nasal Lavage Fluid" by people in this website by year, and whether "Nasal Lavage Fluid" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nasal Lavage Fluid" by people in Profiles.
-
Khatri M, Bello D, Gaines P, Martin J, Pal AK, Gore R, Woskie S. Nanoparticles from photocopiers induce oxidative stress and upper respiratory tract inflammation in healthy volunteers. Nanotoxicology. 2013 Aug; 7(5):1014-27.
-
Rohde G, Borg I, Wiethege A, Kauth M, Jerzinowski S, An Duong Dinh T, Bauer TT, Bufe A, Schultze-Werninghaus G. Inflammatory response in acute viral exacerbations of COPD. Infection. 2008 Oct; 36(5):427-33.
-
Rohde G, Wiethege A, Borg I, Kauth M, Bauer TT, Gillissen A, Bufe A, Schultze-Werninghaus G. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax. 2003 Jan; 58(1):37-42.
-
Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S, Brown BW, Desch JK, Norbash AM, Conrad CK, Guggino WB, Flotte TR, Wine JJ, Carter BJ, Reynolds TC, Moss RB, Gardner P. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther. 2002 Jul 20; 13(11):1349-59.